首页 | 本学科首页   官方微博 | 高级检索  
     


Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)
Authors:Alejo Rodriguez-Vida  Aristotelis Bamias  Emilio Esteban  Maria Isabel Saez  Marta Lopez-Brea  Daniel Castellano  Cristina Caballero  Jose Luis Gonzalez-Larriba  Emiliano Calvo  Sonia Macia  Alain Ravaud  Joaquim Bellmunt
Affiliation:1. Hospital del Mar-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain;2. Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece;3. Hospital Central de Asturias, Oviedo, Spain;4. UGCI of Medical Oncology, Hospitales Regional and Universitario Virgen de la Victoria, Málaga, Spain

Institute of Biomedical Research (IBIMA), Málaga, Spain;5. Hospital Marqués de Valdecilla, Santander, Spain;6. Hospital 12 de Octubre, Madrid, Spain;7. Hospital General Universitario de Valencia, Valencia, Spain;8. Hospital Clínico San Carlos, Madrid, Spain;9. START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain;10. Pivotal, Madrid, Spain;11. Hôpital Saint André, Bordeaux University Hospital, Bordeaux, France

Abstract:
Keywords:renal carcinoma  sunitinib  everolimus  alternating schedules  resistance  treatment sequencing  #uroonc  #KidneyCancer  #kcsm
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号